Data complete?
Evaluation appropriate?
Will the patient experience a decreased clearance of the chemotherapeutic agent?
The risk of a toxic reaction to the chemotherapeutic agent is
Caution: A qualified health practitioner should verify all results.Keep patient data confidential and comply with all legal requirements.
Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited
Purpose: To evaluate a patient who is about to undergo chemotherapy with either docetaxel or irinotecan for a polymorphism in the ABCB1 gene.
Specialty: Toxicology, Emergency Medicine, Critical Care, Genetics
Objective: laboratory tests, pharmacogenetics
ICD-10: C00-C14, C16, C18, C19, C20, C21, C34, C50-C50, C61,
